Literature DB >> 18083113

Mutational analysis of type IV collagen alpha5 chain, with respect to heterotrimer formation.

Takehiro Kobayashi1, Toshio Kakihara, Makoto Uchiyama.   

Abstract

Alport syndrome (AS) is caused by mutations in type IV collagen alpha3, alpha4, and alpha5 chains. The three chains form a heterotrimer. In this study, we introduced 12 kinds of missense and three kinds of nonsense mutations, corresponding to AS mutations, into the NC1 domain of alpha5(IV) and characterized the mutant chains. Nine alpha5(IV) chains with amino acid substitutions and all three truncated alpha5(IV) chains did not form a heterotrimer and were not secreted from cells. Three alpha5(IV) chains with amino acid substitutions did, however, form heterotrimers in cells, but these were not secreted from cells. These findings indicate that a defect in heterotrimer formation is the main molecular mechanism underlying the pathogenesis of AS caused by mutation in the NC1 domain. We also showed that even a single amino acid deletion in the carboxyl-terminal region markedly affected the heterotrimerization, indicating that the carboxyl-terminal end is indispensable for heterotrimer formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18083113     DOI: 10.1016/j.bbrc.2007.12.037

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Identification of the NC1 domain of {alpha}3 chain as critical for {alpha}3{alpha}4{alpha}5 type IV collagen network assembly.

Authors:  Valerie LeBleu; Malin Sund; Hikaru Sugimoto; Gabriel Birrane; Keizo Kanasaki; Elizabeth Finan; Caroline A Miller; Vincent H Gattone; Heather McLaughlin; Charles F Shield; Raghu Kalluri
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

2.  Mutant-type alpha5(IV) collagen in a mild form of Alport syndrome has residual ability to form a heterotrimer.

Authors:  Takehiro Kobayashi; Makoto Uchiyama
Journal:  Pediatr Nephrol       Date:  2010-02-04       Impact factor: 3.714

Review 3.  Variations of type IV collagen-encoding genes in patients with histological diagnosis of focal segmental glomerulosclerosis.

Authors:  Erol Demir; Yasar Caliskan
Journal:  Pediatr Nephrol       Date:  2019-06-28       Impact factor: 3.714

4.  Evidence for activation of the unfolded protein response in collagen IV nephropathies.

Authors:  Myrtani Pieri; Charalambos Stefanou; Apostolos Zaravinos; Kamil Erguler; Kostas Stylianou; George Lapathitis; Christos Karaiskos; Isavella Savva; Revekka Paraskeva; Harsh Dweep; Carsten Sticht; Natassa Anastasiadou; Ioanna Zouvani; Demetris Goumenos; Kyriakos Felekkis; Moin Saleem; Konstantinos Voskarides; Norbert Gretz; Constantinos Deltas
Journal:  J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 10.121

5.  Trimerization and Genotype-Phenotype Correlation of COL4A5 Mutants in Alport Syndrome.

Authors:  Misato Kamura; Tomohiko Yamamura; Kohei Omachi; Mary Ann Suico; Kandai Nozu; Shota Kaseda; Jun Kuwazuru; Tsuyoshi Shuto; Kazumoto Iijima; Hirofumi Kai
Journal:  Kidney Int Rep       Date:  2020-01-30

6.  Comparison between conventional and comprehensive sequencing approaches for genetic diagnosis of Alport syndrome.

Authors:  Tomohiko Yamamura; Kandai Nozu; Shogo Minamikawa; Tomoko Horinouchi; Nana Sakakibara; China Nagano; Yuya Aoto; Shinya Ishiko; Koichi Nakanishi; Yuko Shima; Hiroaki Nagase; Rini Rossanti; Ming J Ye; Yoshimi Nozu; Shingo Ishimori; Naoya Morisada; Hiroshi Kaito; Kazumoto Iijima
Journal:  Mol Genet Genomic Med       Date:  2019-07-30       Impact factor: 2.183

7.  Last Nucleotide Substitutions of COL4A5 Exons Cause Aberrant Splicing.

Authors:  Yuya Aoto; Tomoko Horinouchi; Tomohiko Yamamura; Atsushi Kondo; Sadayuki Nagai; Shinya Ishiko; Eri Okada; Rini Rossanti; Nana Sakakibara; China Nagano; Hiroyuki Awano; Hiroaki Nagase; Yuko Shima; Koichi Nakanishi; Masafumi Matsuo; Kazumoto Iijima; Kandai Nozu
Journal:  Kidney Int Rep       Date:  2021-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.